International Business MachinesIBM's Anderon venture finalized a $1 billion CHIPS Act award plus $1 billion IBM investment for its quantum wafer foundry.

Anderon LLC, an IBM company, has finalized a $1 billion award under the CHIPS and Science Act with the U.S. Department of Commerce to accelerate its research and development of U.S.-based quantum wafer manufacturing. The award, first announced in May under a letter of intent between the Department and IBM, supports Anderon's state-of-the-art 300-millimeter pure-play quantum wafer foundry, which is backed by an additional $1 billion investment from IBM. Headquartered in Albany, New York, the venture serves the quantum industry as a pure-play foundry offering quantum wafer manufacturing to customers across the ecosystem. Anderon CEO Mukesh Khare said the agreement strengthens the company's ability to deliver the manufacturing scale the quantum industry needs, while Jay Gambetta, Director of IBM Research and an IBM Fellow, said Anderon's wafer fabrication focus gives IBM the foundation to execute its quantum roadmap. The company said its first quantum wafers are now running through its manufacturing facility, an early production milestone demonstrating its ability to translate advanced pre-production research into commercial-grade quantum wafer technologies.
International Business MachinesIBM's Anderon venture finalized a $1 billion CHIPS Act award plus $1 billion IBM investment for its quantum wafer foundry.